Publication

Deconstructing and Reconstructing the Complexity of Tau pathology

Related publications (54)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Deconstructing and Reconstructing the Complexity of Tau pathology

Graph Chatbot

Chat with Graph Search

FTLD-TDP assemblies seed neoaggregates with subtype-specific features via a prion-like cascade

Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology

Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c']dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer's disease and other tauopathies

Effects of sedimentation, microgravity, hydrodynamic mixing and air-water interface on alpha-synuclein amyloid formation

Gold nanoparticles as a new tool in amyloid studies

Phosphorylation of the overlooked tyrosine 310 regulates the structure, aggregation, and microtubule- and lipid-binding properties of Tau

Application of anti-amyloid beta immunization using encapsulated cell technology in mouse models of Alzheimer's disease

A viral vector based in vivo model of tauopathy to explore therapeutic strategies against tau pathology

Protein Semisynthesis Provides Access to Tau Disease-Associated Post-translational Modifications (PTMs) and Paves the Way to Deciphering the Tau PTM Code in Health and Diseased States

Calpain-mediated tau fragmentation is altered in Alzheimer's disease progression